Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018
Author:
Affiliation:
1. Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville
2. Southern HIV and Alcohol Research Consortium (SHARC), University of Florida, Gainesville
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2768791/jama_song_2020_ld_200041.pdf
Reference5 articles.
1. Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement.;US Preventive Services Task Force;JAMA,2019
2. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015.;Smith;Ann Epidemiol,2018
3. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014-2016.;Huang;MMWR Morb Mortal Wkly Rep,2018
4. Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care.;Silapaswan;J Gen Intern Med,2017
5. Who treats patients with diabetes and compensated cirrhosis.;Liu;PLoS One,2016
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding Opportunities for Prescribing Pre-exposure Prophylaxis (PrEP) at Two Academic Medical Centers in a High Priority Jurisdiction for Ending the HIV Epidemic;2024-07-26
2. Assessing the dynamics of PrEP adoption in a national-scale physician network;Social Networks;2024-07
3. Psychiatry and Family Medicine Residents’ Likelihood of Prescribing HIV Pre-Exposure Prophylaxis (PrEP) to Patients with Mental Illness and HIV Vulnerability;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-03-25
4. Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance;AIDS;2024-02-29
5. Barriers and Facilitators to Long-Acting Injectable HIV PrEP Implementation in Primary Care Since Its Approval in the United States;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3